Amredobresib CAS No.1610044-98-8
Amredobresib CAS No.1610044-98-8
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-R-2538 | 5mg | 340.00 | + Add to cart |
|
| R-R-2538 | 10mg | 580.00 | + Add to cart |
|
|
|
||||
Product description
Amredobresib/CAS No.1610044-98-8 is a potent inhibitor of BET. Amredobresib inhibits the binding of bromodomains to acetylated lysines on histone H3 and H4 and thus acts as important regulators of gene transcription. Amredobresib is useful for the research of acute myeloid leukemia (AML) and cancer (extracted from patent WO2019145410A1 and WO2021175824A1).
| Appearance | N/A |
|---|---|
| Molecular Weight | 467.57 |
| Purity | >90% |
| CAS | 1610044-98-8 |
| Formula | C26H29N9 |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of Amredobresib CAS No.1610044-98-8
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


